[1]马陈 沈霖△ 杨艳萍 帅波 徐晓娟 夏雪.青娥丸对绝经后骨质疏松症患者血清癌胚抗原相关细胞黏附分子1,β-链蛋白水平及骨密度的影响[J].中国中医骨伤科杂志,2017,25(02):15-18.
　MA Chen SHEN Lin YANG Yanping SHUAI Bo XU Xiaojuan XIA Xue.Effect of Qing'e Pill on Serum CEACAM1,β-catenin Levels and Bone Mineral Density in Patients with Postmenopausal Osteoporosis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2017,25(02):15-18.
点击复制

青娥丸对绝经后骨质疏松症患者血清癌胚抗原相关细胞黏附分子1,β-链蛋白水平及骨密度的影响()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第25卷
期数:
2017年02期
页码:
15-18
栏目:
临床研究
出版日期:
2017-02-15

文章信息/Info

Title:
Effect of Qing'e Pill on Serum CEACAM1,β-catenin Levels and Bone Mineral Density in Patients with Postmenopausal Osteoporosis
文章编号:
1005-0205(2017)02-0015-04
作者:
马陈1 沈霖1△ 杨艳萍1 帅波1 徐晓娟1 夏雪1
1华中科技大学同济医学院附属协和医院中西医结合科 (武汉,430022) △通信作者 E-mail:shenlinhb@sina.com
Author(s):
MA Chen1 SHEN Lin1△ YANG Yanping1 SHUAI Bo1 XU Xiaojuan1 XIA Xue1
1Department of Integrated Traditional Chinese and Western Medicine,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China.
关键词:
青娥丸;  绝经后骨质疏松症;  癌胚抗原相关粘附分子1;  β-链蛋白;  骨密度
Keywords:
Qing'e pill;  postmenopausal osteoporosis;  carcinoembryonic antigen related adhesion 1;  β-catenin;  bone mineral density
分类号:
R274.39
文献标志码:
A
摘要:
目的:观察古方青娥丸治疗对绝经后骨质疏松症血清患者癌胚抗原相关细胞黏附分子1(CEACAM1),β-链蛋白(β-catenin)及骨密度(BMD)的影响。方法:将80例绝经后骨质疏松患者随机分为青娥丸治疗组(试验组)及安慰剂对照组(对照组),治疗6个月。分别在治疗前、服药6个月后检测患者血清中CEACAM1及β-catenin水平,双能X线吸收法(DEXA)测定腰椎正位、股骨颈、Ward's三角和大粗隆的BMD。结果:试验组患者血清CEACAM1和β-catenin的水平明显增加(P<0.01),对照组CEACAM1和β-catenin水平无明显变化。试验组BMD较治疗前无明显变化(P>0.05),对照组BMD较治疗前明显降低(P<0.01)。结论:青娥丸能够提高绝经后骨质疏松患者血清CEACAM1和β-catenin的水平,并能有效维持绝经后骨质疏松患者的骨密度。
Abstract:
Objective:To observe the effect of ancient recipe Qing'e pill on serum carcinoembryonic antigen related cell adhesion molecule 1(CEACAM1),beta chain protein(β-catenin)and bone mineral density(BMD)in patients with postmenopausal steoporosis.Methods:All 80 cases of postmenopausal osteoporosis were randomly divided into Qing'e pill treatment group and placebo control group(control group),and they were treated for 6 months.The serum CEACAM1 and β-catenin levels were detected before treatment and 6 months after treatment respectively.The BMD of lumbar spine,femoral neck,Ward's triangle and greater trochanter were determined by dual energy X-ray absorptiometry(DEXA).Results:The levels of serum CEACAM1 and β-catenin were significantly increased in the experimental group(P<0.01),while the levels of CEACAM1 and β-catenin were not changed in the control group.The BMD of Qing'e pill treatment group had no obvious change than before treatment(P>0.05),and BMD in the placebo group was significantly lower than that before treatment(P<0.01).Conclusion:Qing'e pill can improve postmenopausal osteoporosis patients' serum CEACAM1 and β-catenin levels,and it can maintain the bone density in postmenopausal osteoporosis patients effectively.

参考文献/References:

[1] Ma C,Shuai B,Shen L,et al.Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women:correlation with β-catenin and bone mineral density[J].Osteoporos Int,2016,27(4):1529-1535.
[2] Xu XJ,Shen L,Yang YP,et al.Serum beta-catenin levels associated with the ratio of RANKL/OPG in patients with postmenopausal osteoporosis[J].Int J Endocrinol,2013:534352.
[3] Michigami T,Shimizu N,Williams PJ,et al.Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity[J].Blood,2000,96(5):1953-1960.
[4] Pearse RN,Sordillo EM,Yaccoby S,et al.Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression[J].Proc Natl Acad Sci USA,2001,98(20):11581-11586.
[5] Tanaka Y,Maruo A,Fujii K,et al.Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts:characteristic involvement of cell cycle regulators[J].J Bone Miner Res,2000,15(10):1912-1923.
[6] 翁泽斌,颜翠萍,张志杰,等,不同炮制品入药的青娥丸含药血清对人成骨细胞增殖、分化及矿化的影响[J].中国实验方剂学杂志,2015,21(6):165-168.
[7] 吴海洋,索欢,王平,等.绝经后骨质疏松症的临床中药治疗进展[J].中国骨质疏松杂志,2015,21(2):367-371.
[8] 徐晓娟,沈霖,杨艳萍,等.青娥丸对绝经后骨质疏松症患者骨密度和骨转换标志物的影响[J].中国中医骨伤科杂志,2013,21(6):8-10.
[9] Mauck KF,Clarke BL.Diagnosis,screening,prevention,and treatment of osteoporosis[J].Mayo Clin Proc,2006,81(5):662-672.
[10] 赵光,沈霖,杨艳萍.青娥丸对绝经后骨质疏松症患者骨密度血清MMP-2水平及骨代谢指标的影响[J].中西医结合研究,2012,4(3):113-117.
[11] 沈霖,杜靖远,杨家玉,等.青娥丸加味治疗老年性骨质疏松症52例观察[J].湖北中医杂志,1994,16(3):16-18.
[12] Mulcahy LE,Taylor D,Lee TC,et al.RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells[J].Bone,2011,48(2):182-188.
[13] Gifre L,Ruiz-Gaspa S,Monegal A,et al.Effect of glucocorticoid treatment on Wnt signalling antagonists(sclerostin and Dkk-1)and their relationship with bone turnover[J].Bone,2013,57(1):272-276.
[14] Jin L,Li Y,Chen CJ,et al.Direct interaction of tumor suppressor CEACAM1 with beta catenin:identification of key residues in the long cytoplasmic domain[J].Exp Biol Med(Maywood),2008,233(7):849-859.
[15] Heckt T,Bickert T,Jeschke A,et al.Increased osteoclastogenesis in mice lacking the carcinoembryonic antigen-related cell adhesion molecule 1[J].Plos One,2014,9(12):e114360.
[16] Huang S,Kaw M,Harris MT,et al.Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1[J].Bone,2010,46(4):1138-1145.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金项目(81473492,81403257)
更新日期/Last Update: 2017-09-08